Abstract
446PD - Phase I study of AMG 510, a novel molecule targeting KRAS G12C mutant solid tumours
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1093/annonc/mdz244.008
Journal: Annals of Oncology | Publication Date: Oct 1, 2019 |
Citations: 40 | License type: publisher-specific-oa |
446PD - Phase I study of AMG 510, a novel molecule targeting KRAS G12C mutant solid tumours
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.